Midi vs Hers Menopause: Which Online HRT Provider Actually Fits You? (2026)

Consumer information only — not medical advice. Editorial standards · How we compared

Midi vs Hers menopausecomes down to one thing almost every other comparison skips: these two don't really go head-to-head, because they're built on opposite models. So here's the short version, up front.

Pick Midi Health if you have PPO insurance or a more complicated situation — several symptoms stacked together, a need for lab work, or a cancer-survivorship question that needs a clinician guiding you rather than a simple medication subscription. Midi is in-network with most PPO plans and works in all 50 states. Pick Hers if you want the simplest, most predictable cash-pay path: flat pricing from about $79 a month, medication included, and no insurance maze.

Both prescribe FDA-approved estradiol and progesterone for menopause. Midi alsooffers compounded options in some cases — and “compounded” isn't the same as “FDA-approved,” which is one of a few things about these two that surprise people. We'll clear them up below.

Quick gut-check — which row sounds like you?

Midi vs Hers menopause: who should choose each?

Midi Health is an insurance-based virtual menopause clinic available in all 50 states, with self-pay visits at $250 (first) and $150 (follow-up), or about $50 out-of-pocket per visit with PPO insurance. Hers is a flat-rate cash-pay subscription, available in most states, starting around $79/month for oral medication or $134/month for patches — medication included. Both prescribe FDA-approved estradiol and progesterone.

Most “Midi vs Hers” pages argue about price like the two are the same product. They aren't. Midi is a clinic that takes your insurance. Hers is a subscription that ships your meds. Once you see it that way, the right choice usually picks itself.

Sources: Midi Health pricing, how-it-works, help center, and HRT-shortage pages; Hers menopause and perimenopause pages; Reuters. All verified June 4, 2026. Full citations at the bottom.

First, the question under the question: is online menopause HRT safe — and are you “allowed”?

For healthy women under 60 or within 10 years of menopause, major medical groups including the Menopause Society conclude that the benefits of hormone therapy generally outweigh the risks. In November 2025, the FDA began removing the decades-old “boxed warning” from menopause hormone therapy, and in February 2026it approved the first updated labels. It's still a personal decision to make with a clinician, and it isn't right for everyone.

A lot of women have wanted help for years but held back because of one scary line they read in 2002 — that hormone therapy raises cancer risk. That fear came from early readings of a big study (the Women's Health Initiative) that have since been heavily revisited. The result: of roughly 41 million U.S. women aged 45 to 64 in 2020, only about 2 million were on hormone therapy (Reuters, Feb 2026).

What the FDA did, on the record:

The Menopause Society's position: risks are low for younger, healthy women who start hormone therapy close to the transition, and higher for women who start much older or many years out. Some evidence points to lower fracture risk and lower all-cause mortality when therapy starts within 10 years of menopause.

The bottom line: if you're a generally healthy woman in your 40s or 50s with hot flashes, night sweats, sleep problems, or vaginal dryness, you are not being reckless for wanting treatment. You're squarely inside what the guidelines now support.

The one thing we'll tell you straight: neither Midi nor Hers is right for everyone

Online menopause care is a strong fit for healthy women without red flags — but it's the wrong first step for some people. See a local clinician first if you have unexplained vaginal bleeding, a history of certain cancers, blood clots, stroke, heart attack, or liver disease, or if you're pregnant or might be. If you're on Medicaid or Medicare, the money math also changes.

Talk to a clinician in person before starting online HRT if you have any of these:

• !Unexplained vaginal bleeding
• !A current or possible pregnancy
• !A history of breast cancer or other hormone-sensitive cancer
• !A history of blood clots, stroke, or heart attack
• !Active liver disease
• !New, severe, or fast-changing symptoms that need a hands-on exam

A cancer history doesn't always rule out treatment — but it's a clinician-led decision, not a “pick a subscription” one. Midi runs a dedicated cancer-survivorship program and often leans on non-hormonal options for that group.

Two coverage red flags that change the decision:

How much does Midi vs Hers cost in the first 90 days?

Hers is cheaper and easier to predict for simple cash-pay care — about $237 over 90 days on an oral plan or $402 on a patch plan, medication included. Midi is often cheaper if your insurance works well (around $50 out-of-pocket per visit on average), but self-pay it runs about $400 for a first visit plus one follow-up — before labs and prescriptions. The real winner depends on your insurance.

Assumptions: Hers' oral math uses $79/month on a 12-month plan; patch math uses $134/month on a 12-month plan — confirm your exact price after the assessment. Midi's self-pay math assumes one initial visit plus one follow-up, excluding labs and medication. Midi's insurance figure is an average the company reports; your plan decides your real number.
Sources: Midi Health pricing and help center; Hers; Reuters. Verified June 4, 2026.

One more lever worth knowing: during the current hormone shortage, Midi also sells lower-cost compounded options out of pocket — estradiol gel from $60/month, progesterone capsules from $35/month, and estradiol cream from $45/month. Compounded drugs are not FDA-approved, but they can be a cheaper monthly route if your clinician decides they're right for you.

The insight most comparison pages miss:stop asking “which is cheaper?” Ask “am I paying for a clinical visit, or for a medication subscription?” With Midi, you're paying for a clinician's time — insurance can make that cheap, but without it the fees add up. With Hers, you're paying for a flat plan with meds in the box — the easiest number to predict.

Does Midi or Hers take insurance?

Midi is the one to check first if you have PPO or commercial insurance — it's in-network with most PPO plans, and patients pay around $50 out-of-pocket per visit on average. Hers doesn't bill insurance at all; it's cash-pay by design. Neither works with Medicare or Medicaid for covered care.

A warning worth more than it looks: “takes insurance” does not mean “cheap.” Your real cost depends on your plan. Confirm before your first visit. Ask your insurer:

• ›What’s my specialist copay?
• ›Have I met my deductible?
• ›Is telehealth covered on my plan?
• ›Are labs and imaging covered?
• ›Are prescriptions covered, and at what tier?
• ›Are follow-up visits billed the same way as the first?

What HRT medications can Midi vs Hers prescribe for menopause?

Hers offers FDA-approved estradiol (pill or patch), micronized progesterone, and estradiol vaginal cream. Midi offers the same FDA-approved building blocks plus vaginal rings, gels, and non-hormonal options, and additionally offers compounded estradiol and progesterone out of pocket. Compounded drugs are not FDA-approved. In both cases, a licensed clinician decides what's appropriate for you.

Two categories, defined plainly:

If you specifically want FDA-approved-only care, both deliver it. If you want the option of a compoundedformula — say, during the patch shortage — Midi is the one that offers it, with the clear caveat that compounded isn't FDA-approved.

On testosterone: there is no FDA-approved testosterone formulation specifically indicated for women in the U.S., testosterone is a Schedule III controlled substance, and any prescription must come from a clinician after evaluation. Neither service treats it as a casual menopause add-on, and neither should.

Is Midi or Hers better for estrogen patches?

If you specifically want an estradiol patch and you're paying cash, Hers is worth checking first — it says it secured steady patch supply during a national shortage, with kits from $134/month. Midi can also prescribe patches, often through your insurance, and offers gel or compounded alternatives if patches are hard to get. Confirm availability either way.

Demand for estrogen patches has exploded — patch use more than tripled between 2018 and early 2026 (Truveta analysis, via Healthline, April 2026) — and it's outrun supply. Industry sources told Reuters the shortage could last up to three years. The FDA has not officially declared a national shortage, but pharmacies across the country are reporting inconsistent stock.

What this means for your choice:

• Hers:

  Said in April 2026 that it had secured dependable estrogen patch supply for eligible patients, with kits from $134/month. That’s a company statement, not an independent audit — but it’s on the record.

• Midi:

  Can prescribe patches through your insurance and pharmacy. Because of the shortage, Midi’s clinicians can switch you to an alternative — a daily gel, or its compounded estradiol options — if patches are out of stock. Compounded isn’t FDA-approved.

If patches are hard to find in your area, you have more options than just the patch. Estrogen also comes as gels, sprays, and oral tablets, which sidestep the patch crunch entirely. Midi's broader form list — including compounded gel — is an advantage here.

Is Midi or Hers better for perimenopause?

Midi is usually the better first stop for perimenopause, because its live-visit model handles the extra uncertainty that comes with it. Hers treats perimenopause too, but states clearly that hormone therapy is not FDA-approved for perimenopause specifically and is prescribed off-label at a provider's discretion. That's normal and legal — but perimenopause often needs more conversation than a quick plan.

Perimenopause is notjust “early menopause where you start estrogen.” It's messier. Cycles get irregular, symptoms come and go, you can still get pregnant, and bleeding changes sometimes need a closer look.

• →

  Perimenopause + uncertainty + insurance:

  Midi first. A 30-minute visit with a menopause-trained clinician is built for sorting out what’s actually going on.

• →

  Perimenopause + cash-pay + clear, simple symptoms:

  Hers is worth checking.

• →

  Irregular or heavy bleeding, or other red flags:

  See a local clinician first. Don’t let convenience skip a needed exam.

Which is more hands-on: Midi's video visits or Hers' app care?

Midi is more hands-on — you have a live video visit (30 minutes for your first, 15 for follow-ups) with a clinician who can order labs. Hers is more streamlined — an online intake reviewed by a provider, then ongoing app messaging with a care team available around the clock. One trades convenience for clinical depth; the other does the reverse.

If you've ever been rushed or brushed off in a doctor's office, the visit model matters more than it sounds. Convenience is real. So is having someone with time to hear your full history — what you've tried, your bleeding patterns, your risk factors — before writing a prescription.

Midi isn't a flat monthly subscription.If a single predictable price is what you want most, Hers is easier. But because Midi runs like a real clinic — live visits, labs, a workup when needed — it can handle the complicated cases a ship-it subscription isn't designed for.

“Got a same day appointment and they took my insurance.”

Is Midi or Hers available in my state?

Midi's virtual care is available in all 50 states, accepted by most PPO plans. Hers is available in most states but not all — at its October 2025 launch it was offered everywhere except North Carolina and Arkansas. Availability can change, so confirm your state during each platform's intake before you commit time.

The fastest way to skip the guesswork: run the intake (it gates by state before you pay) or take the quiz, which routes you by state, insurance, and symptoms in one go.

Before you pay: the checklist neither company hands you

Before you commit to Midi or Hers, confirm the details that change at checkout — state availability, real insurance cost, whether labs and meds are included, the medication form you want, follow-up and cancellation terms, and whether your history is a fit for online care.

What we actually verified

We don't ask you to take our word for it. Here's exactly what we confirmed, and how — sorted by how solid each fact is.

We separate the two kinds of facts on purpose: money facts (prices, coverage, states) come from each provider and get re-checked monthly; medical facts (safety, FDA status) come from the FDA and medical societies. Our recommendations are editorial conclusions based on those facts — not medical advice.

How we compared Midi vs Hers

We compared Midi and Hers on the factors that decide real-world fit: cost predictability, insurance, clinical depth, medication options, state availability, labs, and safety limits. Commercial facts came from provider pages and current reporting; medical facts came from the FDA and the Menopause Society.

We weight the categories that matter for a medical decision: insurance fit and cost predictability (the single biggest difference between these two), clinical depth, medication transparency, access and speed, and honest limits. We don't run a fake “9.7/10” score. Midi wins some categories (clinical depth, insurance, breadth, compounded options). Hers wins others (price simplicity, speed, cash-pay access). Which set matters more is up to you.

What if neither one fits?

If you're on Medicaid or Medicare, have red-flag symptoms, or want something neither service offers, Midi and Hers may not be your answer. A few situations point elsewhere: if you need covered care (Medicaid/Medicare), a local in-network clinician will likely cost less; if you have red flags, get an in-person evaluation first (see the list above); and if you want something outside both lineups, our full online HRT provider comparison covers more options. When in doubt, the quiz is the fastest way to find your lane without opening ten tabs.

Frequently asked questions: Midi vs Hers for menopause

Still not sure which HRT program is right for you?

The HRT Index is an independent comparison resource for HRT telehealth providers. We are not a medical provider, and this page is not medical advice. Talk to a licensed clinician about your symptoms, history, and risks before starting or changing any treatment.